BIOPHTA
A preclinical biotech company developing technology for the treatment of eye diseases
BIOPHTA has raised €6.5M across 1 funding round from 5 investors, most recently a Seed round in Jun 2024. Based in Paris, France; active in Healthtech. Data as of 28 Oct 2026.
Paris, Francewww.biophta.com ↗
Total raised
€6.5M
€6,500,000
Funding rounds
1
Investors
5
distinct backers
Active since
2024-06
latest 2024-06
Funding by year
EUR raised per yearBIOPHTA — funding by year — interactive chart.
Data table
| BIOPHTA — funding by year | |
|---|---|
| 2024 | €6.5M |
Signals
High confidenceRaise-next likelihood11
base rate 44% for Seed
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-06-03 | Seed | €6.5M | Elaia Partners,Go Capital,HTL Biotechnology,UI Investissement,Unither Pharmaceuticals | View deal → |
Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData